Reporting Data Item

Business Justification

Definition

Note: Where ‘NHS Wales Data Dictionary’ the definition is as per the Data Dictionary.

Permissible Values

9. RADIOTHERAPY

9.0

ENCDv4.5b (10.8)

Date treatment started (radiotherapy)

To determine the time interval between referral and diagnosis by the specialist team and the start of treatment. Required to be able to the measure survival time from the start of treatment. To enable the date of first definitive treatment to be recorded.

The date on which the radiotherapy first administered.

9.1

ENCDv4.5b (10.6)

Treatment intent (radiotherapy)

To assess patterns of radiotherapy practice for comparisons with best practice guidelines.

The intended outcome of the radiotherapy to be administered.

Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review.

•     Adjuvant

•     Neoadjuvant

•     Radical (curative)

•     Palliative

9.2

Radiotherapy type

This data item is required to distinguish which type of radiotherapy is administered to a patient.

The type of radiotherapy administered.

Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review.

•     Teletherapy

•     Brachytherapy

9.3

NBOCAP

WBCA

Timing of radiotherapy

Different radiotherapy schedules require different analysis of outcomes.

The schedule of the radiotherapy treatment. Definitions of the permissible vales are as follows:

•     Short course immediate surgery: the radiotherapy treatment course will be administered over a period of 5 days followed by surgery on the agreed planned surgical date (within 1 week of completing radiotherapy).

•     Short course delayed surgery: the radiotherapy treatment course will be administered over a period of 5 days followed by surgery which was carried out after the agreed planned surgical date (later than 1 week of completing radiotherapy).

•     Long course chemo-radiotherapy: the concurrent chemo-radiotherapy treatment course will be administered over a period of 5 weeks (approximately 8 week gap to prior to surgery).

*all long and short course radiotherapy treatments will be completed within the specified time periods of 5 days or 5 weeks respectively.

Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review.

•     Short course immediate surgery

•     Short course delayed surgery

•     Long course chemo-radiotherapy